Healthcare provider profile · identity verified

Arielle Fields, M.D

Internal Medicine · NEW HOPE, PA · NPI 1205193448

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	937	232
Amlodipine Besylate	Amlodipine Besylate	643	179
Albuterol Sulfate Hfa	Albuterol Sulfate	606	155
Losartan Potassium	Losartan Potassium	413	109
Gabapentin	Gabapentin	401	105
Rosuvastatin Calcium	Rosuvastatin Calcium	377	102
Lisinopril	Lisinopril	328	75
Hydrochlorothiazide	Hydrochlorothiazide	268	80
Furosemide	Furosemide	262	61
Metformin Hcl	Metformin Hcl	262	71
Omeprazole	Omeprazole	262	69
Metoprolol Succinate	Metoprolol Succinate	246	63
Pantoprazole Sodium	Pantoprazole Sodium	224	51
Carvedilol	Carvedilol	207	47
Diclofenac Sodium	Diclofenac Sodium	182	73
Fluticasone Propionate	Fluticasone Propionate	181	55
Eliquis	Apixaban	178	40
Chlorthalidone	Chlorthalidone	156	41
Jardiance	Empagliflozin	152	34
Metformin Hcl Er	Metformin Hcl	149	44
Famotidine	Famotidine	148	39
Montelukast Sodium	Montelukast Sodium	146	32
Tamsulosin Hcl	Tamsulosin Hcl	146	43
Allopurinol	Allopurinol	134	29
Trulicity	Dulaglutide	134	33
Potassium Chloride	Potassium Chloride	131	35
Clopidogrel	Clopidogrel Bisulfate	130	33
Escitalopram Oxalate	Escitalopram Oxalate	125	38
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	120	39
Nifedipine Er	Nifedipine	119	32
Nystatin	Nystatin	114	26
Ezetimibe	Ezetimibe	107	28
Mirtazapine	Mirtazapine	102	30
Duloxetine Hcl	Duloxetine Hcl	97	34
Ozempic	Semaglutide	97	23
Tizanidine Hcl	Tizanidine Hcl	97	38
Trazodone Hcl	Trazodone Hcl	97	24
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	97	23
Pravastatin Sodium	Pravastatin Sodium	94	21
Spironolactone	Spironolactone	88	24
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	87	20
Levothyroxine Sodium	Levothyroxine Sodium	86	22
Metoprolol Tartrate	Metoprolol Tartrate	83	19
Sertraline Hcl	Sertraline Hcl	79	15
Valsartan	Valsartan	78	32
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	70	17
Farxiga	Dapagliflozin Propanediol	66	17
Ammonium Lactate	Ammonium Lactate	65	21
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	63	22
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	62	14
Breo Ellipta	Fluticasone/Vilanterol	62	16
Quetiapine Fumarate	Quetiapine Fumarate	59	18
Simvastatin	Simvastatin	59	17
Bupropion Xl	Bupropion Hcl	53	suppressed
Hydralazine Hcl	Hydralazine Hcl	53	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	16
Humalog Kwikpen U-100	Insulin Lispro	52	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	51	suppressed
Bumetanide	Bumetanide	49	12
Mounjaro	Tirzepatide	49	11
Tramadol Hcl	Tramadol Hcl	49	19
Propranolol Hcl	Propranolol Hcl	47	11
Prednisone	Prednisone	46	38
Fluoxetine Hcl	Fluoxetine Hcl	45	suppressed
Naproxen	Naproxen	44	22
Ibuprofen	Ibuprofen	42	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	15
Xarelto	Rivaroxaban	42	suppressed
Colchicine	Colchicine	41	17
Azelastine Hcl	Azelastine Hcl	40	12
Atenolol	Atenolol	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Alendronate Sodium	Alendronate Sodium	35	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	35	suppressed
Memantine Hcl	Memantine Hcl	35	suppressed
Azithromycin	Azithromycin	34	29
Oxybutynin Chloride Er	Oxybutynin Chloride	34	12
Lidocaine	Lidocaine	33	suppressed
Aripiprazole	Aripiprazole	32	suppressed
Baclofen	Baclofen	32	suppressed
Glipizide	Glipizide	31	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Valacyclovir	Valacyclovir Hcl	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	29
Hydrocortisone	Hydrocortisone	29	suppressed
Meclizine Hcl	Meclizine Hcl	28	13
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	27	suppressed
Tresiba Flextouch U-200	Insulin Degludec	27	suppressed
Fluconazole	Fluconazole	26	15
Triamcinolone Acetonide	Triamcinolone Acetonide	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Entresto	Sacubitril/Valsartan	23	suppressed
Labetalol Hcl	Labetalol Hcl	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Doxepin Hcl	Doxepin Hcl	22	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Latanoprost	Latanoprost	22	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	18
Methimazole	Methimazole	21	suppressed
Nystop	Nystatin	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Calcitriol	Calcitriol	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Arnuity Ellipta	Fluticasone Furoate	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Linzess	Linaclotide	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	11
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Clotrimazole	Clotrimazole	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	17	suppressed
Risperidone	Risperidone	17	suppressed
Ursodiol	Ursodiol	17	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Calcium Acetate	Calcium Acetate	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	15	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Lurasidone Hcl	Lurasidone Hcl	15	suppressed
Repaglinide	Repaglinide	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Finasteride	Finasteride	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	12	suppressed
Methylprednisolone	Methylprednisolone	12	12
Nadolol	Nadolol	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Vivitrol	Naltrexone Microspheres	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Pancreaze	Lipase/Protease/Amylase	11	suppressed
Tramadol Hcl Er	Tramadol Hcl	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error